Αβ-crystallin and laminin-332 are prognostic markers for triple negative breast cancers in a brazilian series

Detalhes bibliográficos
Autor(a) principal: Graudenz, Márcia Silveira
Data de Publicação: 2019
Outros Autores: Uchôa, Diego de Mendonça, Cadore, Ermani, Giacomazzi, Juliana, Callegari-Jacques, Sidia Maria
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFRGS
Texto Completo: http://hdl.handle.net/10183/205020
Resumo: Purpose: Association between increased αβ-crystallin (ABC) and abnormal LN332 (LN332) expression in triple negative (TNBC) and basal-like (BLBC) breast cancers has been suggested recently. This study aims to evaluate ABC and LN332 immunohistochemical expression in a series of TN infiltrating ductal breast carcinomas and its association with clinical-pathological features and prognostic significance. Methods: Microarrays of 69 cases of TNBC cases were scored for the expression of ABC, LN332, CK5/6 and EGFR by immunohistochemistry with linked clinical and pathological data (age, tumor size, lymph node metastases, histological grade and subtype, lymphovascular invasion). Tumors were scored as strong, moderate and weakly positive for these biomarkers. Results: ABC was expressed in 72.7% (48/66) and LN332 in 63.8% (44/69) of cases. ABC immunostaining was predominantly cytoplasmic (73.5%) and LN332 was exclusively cytoplasmic (100%). ABC was expressed in 83% of BLBC, followed by the penta negative profile (17%). The 5-year survival was 0.67 and 0.75 for ABC negative and LN332 positive tumors, respectively. For the BLBC group this probability was 0.67, while in the penta negative group (ABC, LN332, CK5/6 and EGFR) it was only 0.37. ABC-/LN332+ profile was associated with longer probability of non-recurrence (10-years probability: 0.86 for ABC-/LN332+ tumors versus 0.36 for other profiles; P = 0.021) and longer cumulative survival (10-years probability: 1.0 for ABC-/LN332+ tumors versus 0.53 for other profiles; P = 0.031). There was no association between the ABC-negative/LN332-positive profile and BLBC.
id UFRGS-2_3767e08195bcbe35ab662a2a5809a5ec
oai_identifier_str oai:www.lume.ufrgs.br:10183/205020
network_acronym_str UFRGS-2
network_name_str Repositório Institucional da UFRGS
repository_id_str
spelling Graudenz, Márcia SilveiraUchôa, Diego de MendonçaCadore, ErmaniGiacomazzi, JulianaCallegari-Jacques, Sidia Maria2020-01-29T04:08:08Z20192378-3419http://hdl.handle.net/10183/205020001107528Purpose: Association between increased αβ-crystallin (ABC) and abnormal LN332 (LN332) expression in triple negative (TNBC) and basal-like (BLBC) breast cancers has been suggested recently. This study aims to evaluate ABC and LN332 immunohistochemical expression in a series of TN infiltrating ductal breast carcinomas and its association with clinical-pathological features and prognostic significance. Methods: Microarrays of 69 cases of TNBC cases were scored for the expression of ABC, LN332, CK5/6 and EGFR by immunohistochemistry with linked clinical and pathological data (age, tumor size, lymph node metastases, histological grade and subtype, lymphovascular invasion). Tumors were scored as strong, moderate and weakly positive for these biomarkers. Results: ABC was expressed in 72.7% (48/66) and LN332 in 63.8% (44/69) of cases. ABC immunostaining was predominantly cytoplasmic (73.5%) and LN332 was exclusively cytoplasmic (100%). ABC was expressed in 83% of BLBC, followed by the penta negative profile (17%). The 5-year survival was 0.67 and 0.75 for ABC negative and LN332 positive tumors, respectively. For the BLBC group this probability was 0.67, while in the penta negative group (ABC, LN332, CK5/6 and EGFR) it was only 0.37. ABC-/LN332+ profile was associated with longer probability of non-recurrence (10-years probability: 0.86 for ABC-/LN332+ tumors versus 0.36 for other profiles; P = 0.021) and longer cumulative survival (10-years probability: 1.0 for ABC-/LN332+ tumors versus 0.53 for other profiles; P = 0.031). There was no association between the ABC-negative/LN332-positive profile and BLBC.application/pdfengInternational Journal of Cancer and Clinical Research. USA, ClinMed International Library, 2019. Vol. 6, no. 1, ( 2019), p. 1-10.Câncer de mamaαβ crystallinLaminin-332Triple negative breast cancerBasal-like breast cancerΑβ-crystallin and laminin-332 are prognostic markers for triple negative breast cancers in a brazilian seriesEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001107528.pdf.txt001107528.pdf.txtExtracted Texttext/plain40321http://www.lume.ufrgs.br/bitstream/10183/205020/2/001107528.pdf.txtf1d268acd2b0f5a4ac6b844a3f2b8f4eMD52ORIGINAL001107528.pdfTexto completo (inglês)application/pdf1645989http://www.lume.ufrgs.br/bitstream/10183/205020/1/001107528.pdf75e16fbf1ff12987a6b316710239a031MD5110183/2050202020-01-30 05:09:15.08632oai:www.lume.ufrgs.br:10183/205020Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2020-01-30T07:09:15Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.pt_BR.fl_str_mv Αβ-crystallin and laminin-332 are prognostic markers for triple negative breast cancers in a brazilian series
title Αβ-crystallin and laminin-332 are prognostic markers for triple negative breast cancers in a brazilian series
spellingShingle Αβ-crystallin and laminin-332 are prognostic markers for triple negative breast cancers in a brazilian series
Graudenz, Márcia Silveira
Câncer de mama
αβ crystallin
Laminin-332
Triple negative breast cancer
Basal-like breast cancer
title_short Αβ-crystallin and laminin-332 are prognostic markers for triple negative breast cancers in a brazilian series
title_full Αβ-crystallin and laminin-332 are prognostic markers for triple negative breast cancers in a brazilian series
title_fullStr Αβ-crystallin and laminin-332 are prognostic markers for triple negative breast cancers in a brazilian series
title_full_unstemmed Αβ-crystallin and laminin-332 are prognostic markers for triple negative breast cancers in a brazilian series
title_sort Αβ-crystallin and laminin-332 are prognostic markers for triple negative breast cancers in a brazilian series
author Graudenz, Márcia Silveira
author_facet Graudenz, Márcia Silveira
Uchôa, Diego de Mendonça
Cadore, Ermani
Giacomazzi, Juliana
Callegari-Jacques, Sidia Maria
author_role author
author2 Uchôa, Diego de Mendonça
Cadore, Ermani
Giacomazzi, Juliana
Callegari-Jacques, Sidia Maria
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Graudenz, Márcia Silveira
Uchôa, Diego de Mendonça
Cadore, Ermani
Giacomazzi, Juliana
Callegari-Jacques, Sidia Maria
dc.subject.por.fl_str_mv Câncer de mama
topic Câncer de mama
αβ crystallin
Laminin-332
Triple negative breast cancer
Basal-like breast cancer
dc.subject.eng.fl_str_mv αβ crystallin
Laminin-332
Triple negative breast cancer
Basal-like breast cancer
description Purpose: Association between increased αβ-crystallin (ABC) and abnormal LN332 (LN332) expression in triple negative (TNBC) and basal-like (BLBC) breast cancers has been suggested recently. This study aims to evaluate ABC and LN332 immunohistochemical expression in a series of TN infiltrating ductal breast carcinomas and its association with clinical-pathological features and prognostic significance. Methods: Microarrays of 69 cases of TNBC cases were scored for the expression of ABC, LN332, CK5/6 and EGFR by immunohistochemistry with linked clinical and pathological data (age, tumor size, lymph node metastases, histological grade and subtype, lymphovascular invasion). Tumors were scored as strong, moderate and weakly positive for these biomarkers. Results: ABC was expressed in 72.7% (48/66) and LN332 in 63.8% (44/69) of cases. ABC immunostaining was predominantly cytoplasmic (73.5%) and LN332 was exclusively cytoplasmic (100%). ABC was expressed in 83% of BLBC, followed by the penta negative profile (17%). The 5-year survival was 0.67 and 0.75 for ABC negative and LN332 positive tumors, respectively. For the BLBC group this probability was 0.67, while in the penta negative group (ABC, LN332, CK5/6 and EGFR) it was only 0.37. ABC-/LN332+ profile was associated with longer probability of non-recurrence (10-years probability: 0.86 for ABC-/LN332+ tumors versus 0.36 for other profiles; P = 0.021) and longer cumulative survival (10-years probability: 1.0 for ABC-/LN332+ tumors versus 0.53 for other profiles; P = 0.031). There was no association between the ABC-negative/LN332-positive profile and BLBC.
publishDate 2019
dc.date.issued.fl_str_mv 2019
dc.date.accessioned.fl_str_mv 2020-01-29T04:08:08Z
dc.type.driver.fl_str_mv Estrangeiro
info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10183/205020
dc.identifier.issn.pt_BR.fl_str_mv 2378-3419
dc.identifier.nrb.pt_BR.fl_str_mv 001107528
identifier_str_mv 2378-3419
001107528
url http://hdl.handle.net/10183/205020
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv International Journal of Cancer and Clinical Research. USA, ClinMed International Library, 2019. Vol. 6, no. 1, ( 2019), p. 1-10.
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRGS
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Repositório Institucional da UFRGS
collection Repositório Institucional da UFRGS
bitstream.url.fl_str_mv http://www.lume.ufrgs.br/bitstream/10183/205020/2/001107528.pdf.txt
http://www.lume.ufrgs.br/bitstream/10183/205020/1/001107528.pdf
bitstream.checksum.fl_str_mv f1d268acd2b0f5a4ac6b844a3f2b8f4e
75e16fbf1ff12987a6b316710239a031
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv
_version_ 1815447705175982080